Syk from M1 macrophage exosomes drives vascular injury in kidney transplant rejection

Jinxu Miao1, Yuxi Chen1, Zhou Hang1

  • 1Department of Urology, Jiangsu Key Laboratory of Urological Disease Prevention and Treatment, The Second Affiliated Hospital of Nanjing Medical University, Nanjing Medical University, Nanjing, China.

Transplant Immunology
|July 13, 2026
PubMed

Insights

M1 macrophage exosomes, enriched with spleen tyrosine kinase (Syk), drive kidney transplant rejection by activating endothelial cells. Inhibiting Syk in these exosomes reduces vascular injury and rejection signs.

Area of Science:

  • Immunology
  • Transplantation Biology
  • Cell Biology

Background:

  • Antibody-mediated rejection (ABMR) is a major cause of kidney transplant failure, involving inflammation and damage to blood vessels.
  • M1-polarized macrophages accumulate in rejected allografts, but their exosomes' role in vascular injury is unclear.

Purpose of the Study:

  • To investigate the role of exosomes secreted by M1 macrophages (M1-Exos) in endothelial injury during ABMR.
  • To identify specific molecules within M1-Exos mediating this vascular damage.

Main Methods:

  • Transcriptomic and proteomic analysis of M1-Exos to identify key proteins.
  • In vitro functional assays using endothelial cells to assess M1-Exo effects.
  • Inhibition and genetic deletion of identified proteins (Syk) to determine their role.
  • Murine model of renal transplantation to evaluate M1-Exo effects in vivo.

Main Results:

  • M1-Exos significantly induce endothelial activation, upregulating ICAM-1 and VCAM-1.
  • Spleen tyrosine kinase (Syk) was identified as highly enriched in M1-Exos.
  • Exosomal Syk transfer to endothelial cells activates the NLRP3 inflammasome and caspase-1.
  • Inhibition or absence of Syk in M1-Exos reduced endothelial inflammation and ABMR severity in a murine model.

Conclusions:

  • Exosomes derived from M1 macrophages mediate endothelial inflammation and vascular injury in ABMR.
  • Exosomal Syk is a key mediator, transferred from M1 macrophages to endothelial cells, driving inflammasome activation.
  • Targeting exosomal Syk presents a potential therapeutic strategy for mitigating ABMR and improving transplant outcomes.

Related Concept Videos

Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Cytotoxic Edema: Pathophysiology01:21

Cytotoxic Edema: Pathophysiology

Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous supply...
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...